The production of secretory leukocyte protease inhibitor by dendritic cells

Molecular Immunology

Volumn 48, Issue 4, 2011, Pages 630-636

  Vroling, Aram B ^a   Konijn, Tanja ^a   Samsom, Janneke N ^a   Kraal, Georg ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dendritic cells; Mucosal immunity; Protease inhibitors; SLPI

Indexed keywords

CD40 LIGAND; CYTOKINE; LIPOPOLYSACCHARIDE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVATION; IMMUNITY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ADAPTIVE IMMUNITY; ANIMALS; BONE MARROW CELLS; DENDRITIC CELLS; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; KINETICS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MODELS, IMMUNOLOGICAL; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN STRUCTURE, SECONDARY; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SIGNAL TRANSDUCTION;

MUS;

EID: 78650596380     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.11.002     Document Type: Article

References (22)

1. Antonelli A., Ferrari S.M., Fallahi P., Ghiri E., Crescioli C., Romagnani P., Vitti P., Serio M., Ferrannini E. Interferon-alpha-beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists. Cytokine 2010, 50:260-267.
2. Ashcroft G.S., Lei K., Jin W., Longenecker G., Kulkarni A.B., Greenwell-Wild T., Hale-Donze H., McGrady G., Song X.Y., Wahl S.M. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat. Med. 2000, 6:1147-1153.
3. Bingle C.D., Vyakarnam A. Novel innate immune functions of the whey acidic protein family. Trends Immunol. 2008, 29:444-453.
4. Ding A., Thieblemont N., Zhu J., Jin F., Zhang J., Wright S. Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages. Infect. Immun. 1999, 67:4485-4489.
5. Doumas S., Kolokotronis A., Stefanopoulos P. Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect. Immun. 2005, 73:1271-1274.
6. Fakioglu E., Wilson S.S., Mesquita P.M., Hazrati E., Cheshenko N., Blaho J.A., Herold B.C. Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism. J. Virol. 2008, 82:9337-9344.
7. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 1998, 273:18623-18632.
8. Fryksmark U., Ohlsson K., Rosengren M., Tegner H. Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin. Hoppe Seylers Z. Physiol Chem. 1983, 364:793-800.
9. Hiemstra P.S., Fernie-King B.A., McMichael J., Lachmann P.J., Sallenave J.M. Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics. Curr. Pharm. Des. 2004, 10:2891-2905.
10. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176:1693-1702.
11. Jin F., Nathan C.F., Radzioch D., Ding A. Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infect. Immun. 1998, 66:2447-2452.
12. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., Hoshino K., Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 2001, 167:5887-5894.
13. Ma G., Greenwell-Wild T., Lei K., Jin W., Swisher J., Hardegen N., Wild C.T., Wahl S.M. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J. Exp. Med. 2004, 200:1337-1346.
14. McNeely T.B., Shugars D.C., Rosendahl M., Tucker C., Eisenberg S.P., Wahl S.M. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 1997, 90:1141-1149.
15. Nguyen H., Teskey L., Lin R., Hiscott J. Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation. Oncogene 1999, 18:5455-5463.
16. Ninomiya-Tsuji J., Kajino T., Ono K., Ohtomo T., Matsumoto M., Shiina M., Mihara M., Tsuchiya M., Matsumoto K. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 2003, 278:18485-18490.
17. Odaka C., Mizuochi T., Yang J., Ding A. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response. J. Immunol. 2003, 171:1507-1514.
18. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., Gerritsen M.E. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 1997, 272:21096-21103.
19. Py B., Basmaciogullari S., Bouchet J., Zarka M., Moura I.C., Benhamou M., Monteiro R.C., Hocini H., Madrid R., Benichou S. The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane. PLoS ONE 2009, 4:e5006.
20. Samsom J.N., van der Marel A.P., van Berkel L.A., van Helvoort J.M., Simons-Oosterhuis Y., Jansen W., Greuter M., Nelissen R.L., Meeuwisse C.M., Nieuwenhuis E.E., Mebius R.E., Kraal G. Secretory leukoprotease inhibitor in mucosal lymph node dendritic cells regulates the threshold for mucosal tolerance. J. Immunol. 2007, 179:6588-6595.
21. Taggart C.C., Cryan S.A., Weldon S., Gibbons A., Greene C.M., Kelly E., Low T.B., O'Neill S.J., McElvaney N.G. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J. Exp. Med. 2005, 202:1659-1668.
22. Zhu J., Nathan C., Ding A. Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor. Biochim. Biophys. Acta 1999, 1451:219-223.